Treatment Response in Dialysis Anaemia
Predictors of Response to Treatment With Iron and Erythropoietin in Dialysis Anaemia
Sponsor: Imperial College Healthcare NHS Trust
Listed as NCT02707757, this PHASE4 trial focuses on Anaemia and Haemodialysis and remains completed. Sponsored by Imperial College Healthcare NHS Trust, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2021 — May 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jan 2021 — Apr 2021 [monthly]
Unknown Status PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Imperial College Healthcare NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .